JP2010535504A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535504A5 JP2010535504A5 JP2010519930A JP2010519930A JP2010535504A5 JP 2010535504 A5 JP2010535504 A5 JP 2010535504A5 JP 2010519930 A JP2010519930 A JP 2010519930A JP 2010519930 A JP2010519930 A JP 2010519930A JP 2010535504 A5 JP2010535504 A5 JP 2010535504A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- composition
- polypeptide
- seq
- interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96321507P | 2007-08-03 | 2007-08-03 | |
| PCT/US2008/009282 WO2009020553A2 (en) | 2007-08-03 | 2008-08-01 | Chlamydia antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535504A JP2010535504A (ja) | 2010-11-25 |
| JP2010535504A5 true JP2010535504A5 (Direct) | 2012-10-11 |
Family
ID=40341938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010519930A Pending JP2010535504A (ja) | 2007-08-03 | 2008-08-01 | クラミジア抗原 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100260791A1 (Direct) |
| EP (1) | EP2185577A4 (Direct) |
| JP (1) | JP2010535504A (Direct) |
| CN (1) | CN102027003A (Direct) |
| AU (1) | AU2008284352A1 (Direct) |
| CA (1) | CA2695421A1 (Direct) |
| WO (1) | WO2009020553A2 (Direct) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9259463B2 (en) * | 2006-01-16 | 2016-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chlamydia vaccine |
| EP2293815A4 (en) * | 2008-05-22 | 2013-04-03 | Childrens Medical Center | SYNERGISTIC IMMUNOGENIC FUSION PROTEIN POLYSACCHARIDE CONJUGATE |
| EP3413049B1 (en) | 2008-07-01 | 2020-10-28 | Genocea Biosciences Inc. | Antigen screening system |
| CA2835628C (en) | 2011-05-11 | 2023-01-03 | Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
| SI2939025T1 (sl) * | 2012-12-28 | 2018-09-28 | Cellestis Limited | Preizkus celično posredovanega imunskega odziva |
| WO2018175505A1 (en) | 2017-03-20 | 2018-09-27 | Genocea Biosciences, Inc. | Treatment methods |
| EP3651794A1 (en) * | 2017-07-13 | 2020-05-20 | Nanobio Corporation | Chlamydia nanoemulsion vaccine |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69327599T2 (de) | 1992-06-25 | 2000-08-10 | Smithkline Beecham Biolog | Adjuvantien enthaltende Impfstoffzusammensetzung |
| AU685443B2 (en) | 1993-03-23 | 1998-01-22 | Smithkline Beecham Biologicals (Sa) | Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| ATE420171T1 (de) | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| CN1280619A (zh) * | 1997-11-28 | 2001-01-17 | 根瑟特公司 | 沙眼衣原体的基因组序列和多肽,其片段以及其用途,特别是用于诊断、预防和治疗感染 |
| US7041490B1 (en) * | 1997-11-28 | 2006-05-09 | Serono Genetics Institute, S.A. | Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same |
| EP1069910A1 (en) | 1998-04-09 | 2001-01-24 | GlaxoSmithKline Biologicals S.A. | Adjuvant compositions |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6822071B1 (en) * | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6565856B1 (en) * | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| KR100982204B1 (ko) * | 2001-12-12 | 2010-09-14 | 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. | 클라미디아 트라코마티스에 대한 면역화 |
| GB0203403D0 (en) | 2002-02-13 | 2002-04-03 | Chiron Spa | Chlamydia cytotoxic-T cell epitopes |
| MXPA05013260A (es) * | 2003-06-26 | 2006-03-09 | Chiron Corp | Composiciones inmunogenicas para chlamydia trachomatis. |
| CA2633142A1 (en) * | 2005-12-22 | 2007-10-04 | Novartis Vaccines And Diagnostics, S.R.L. | Chlamydial antigens |
| EP2162460A4 (en) | 2007-06-14 | 2012-06-06 | Emergent Product Dev Gaithersburg Inc | VACCINES AGAINST CHLAMYDIA INFECTIONS |
-
2008
- 2008-08-01 CN CN200880110106XA patent/CN102027003A/zh active Pending
- 2008-08-01 CA CA2695421A patent/CA2695421A1/en not_active Abandoned
- 2008-08-01 JP JP2010519930A patent/JP2010535504A/ja active Pending
- 2008-08-01 WO PCT/US2008/009282 patent/WO2009020553A2/en not_active Ceased
- 2008-08-01 AU AU2008284352A patent/AU2008284352A1/en not_active Abandoned
- 2008-08-01 EP EP08794946A patent/EP2185577A4/en not_active Withdrawn
- 2008-08-01 US US12/671,250 patent/US20100260791A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116096735A (zh) | 乙型冠状病毒的预防和治疗 | |
| CN110862435A (zh) | 非洲猪瘟ctl表位多肽及其应用 | |
| JP2010516290A5 (Direct) | ||
| JP2010535504A5 (Direct) | ||
| JP6676661B2 (ja) | ブタ生殖器呼吸器症候群及びブタサーコウイルス関連疾患に対するワクチン組成物 | |
| CN111448208B (zh) | 用于治疗和/或预防异位性皮肤炎的il-31肽免疫原及其剂型 | |
| CN110612118A (zh) | 用于引起针对hbv的免疫应答的病毒样粒子 | |
| JP7146926B2 (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| US20220073946A1 (en) | Virus-like particles of cmv modified by fusion | |
| WO2022127825A1 (zh) | 针对新型冠状病毒感染的疫苗组合物 | |
| KR20150131292A (ko) | 인플루엔자 핵단백질 백신 | |
| CN102000329B (zh) | 一种改造的非致病细菌来源的鞭毛素粘膜佐剂及制备方法 | |
| WO2016178811A1 (en) | Modified h7 hemagluttinin glycoprotein of the influenza a/shanghai/2/2013 h7 sequence | |
| Lu et al. | DNA vaccine ROP 29 from Toxoplasma gondii containing R848 enhances protective immunity in mice | |
| KR20180038557A (ko) | 타겟 폴리펩티드를 제시하기 위한 폴리펩티드 캐리어 및 이의 용도 | |
| JP2017527293A5 (Direct) | ||
| KR101881947B1 (ko) | 기생충 질병에 대한 백신 또는 진단용으로 사용되는 ｌ3 및/또는 ｌ5 공급원의 용도 | |
| WO2023217005A1 (zh) | 串联式杂合三聚体新冠疫苗 | |
| Li et al. | Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice | |
| JP2021524280A (ja) | ハウスダストダニアレルギーの処置および予防 | |
| WO2019228032A1 (zh) | 磷酸化多肽抗原疫苗及其制备方法和应用 | |
| Shen et al. | DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice | |
| CN105198982B (zh) | 基于il-6的抗原表位及其应用 | |
| CN109748952B (zh) | 辅助性表位肽及其应用 | |
| CA3001725C (en) | Modified h7 hemaglutinin glycoprotein of the influenza a/shanghai/2/2013 h7 sequence |